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Figure 3. ERK2 does not affect other lamin A and Rb interactions. (A) ERK2 
does not affect LAP2–Rb interaction. NIH3T3 cells were transfected with 
1 μg each of vector (), HA-ERK2-NLS-wt (wt), and HA-ERK2-DK (DK), 
grown until confluence, and kept in 0.5% CS for 18 h. Cellular lysates 
were immunoprecipitated with an antibody against LAP2 or with pre-
immune serum (PI), and immunoprecipitates (IP) and total lysates (TL) were 
probed for the indicated proteins ( protein of interest).
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
IO
L
O
G
Y
 o
n
 June 17, 2011
jcb.rupress.org
D
ow
nloaded from
 
Published November 29, 2010
JCB: Article
The Rockefeller University Press  $30.00
J. Cell Biol. Vol. 191 No. 5 967–979
www.jcb.org/cgi/doi/10.1083/jcb.201004067 JCB 967
Correspondence to Piero Crespo: crespop@unican.es
Abbreviations used in this paper: DK, kinase-deficient mutant; DMEM, Dulbecco’s 
minimum essential medium; ERK, ERK1/2 MAPK; ERNF, extraction-resistant 
nuclear fraction; FRET, fluorescence resonance energy transfer; GDI, guanine 
dissociation inhibitor; MEF, mouse embryo fibroblast; Rb, retinoblastoma; SNF, 
soluble nuclear fraction; wt, wild type.
Introduction
ERK1/2 MAPKs (ERKs) are cytoplasmic serine/threonine 
kinases that participate in the transduction of signals from the 
surface to the interior of the cell. ERKs play an essential role in 
the conveyance of extracellular stimuli that orchestrate cellular 
proliferation, differentiation, and survival (Raman et al., 2007). 
A major event in these processes is the regulation of cell cycle 
entry and progression. ERKs serve in such a task by different 
mechanisms (for review see Chambard et al., 2007). For ex-
ample, ERKs play a fundamental role in the transit from G0/G1 
to S phase, being required for the transcriptional induction of 
D-type cyclins (Lavoie et al., 1996). Active ERKs translocate to 
the nucleus, where they phosphorylate preexisting transcription 
factors, such as Elk-1, that in turn induce the transcription of im-
mediate early genes like Fos (Gille et al., 1995). Prolonged ERK 
activity results in c-Fos phosphorylation, which stabilizes this 
transcription factor, thereby enabling the induction of cyclin D 
expression several hours after stimulation (Weber et al., 1997; 
Balmanno and Cook, 1999). ERKs also phosphorylate and 
stabilize c-Myc, which directly participates in the trans-
criptional induction of D-type cyclins (Seth et al., 1991; Daksis 
et al., 1994).
Newly synthesized cyclin D forms active complexes with 
the existing Cdks CDK4/6, which undertake the phosphoryla-
tion of the retinoblastoma (Rb) pocket protein, a key step for 
G1/S transition. In its hypophosphorylated state, Rb is bound to 
E2F family transcription factors. Sequential phosphorylation 
of Rb by cyclin D–CDK4/6 and cyclin E-A–CDK2 complexes 
triggers its inactivation and the release of E2F, ensuring cell 
cycle progression and, ultimately, DNA replication (Weinberg, 
1995). Activated ERKs also contribute to Rb phosphorylation 
by regulating CDK2 nuclear translocation by yet unknown 
mechanisms (Keenan et al., 2001). In addition, during mid-G1, 
ERKs promote Rb phosphorylation by cyclin E–CDK2 by 
down-regulating the levels of its inhibitor p27Kip1 (Kerkhoff and 
Rapp, 1997) and titrating it away by promoting the formation 
As orchestrators of essential cellular processes like proliferation, ERK1/2 mitogen-activated protein kinase signals impact on cell cycle 
regulation. A-type lamins are major constituents of 
the nuclear matrix that also control the cell cycle ma-
chinery by largely unknown mechanisms. In this paper, 
we disclose a functional liaison between ERK1/2 and 
lamin A whereby cell cycle progression is regulated. 
We demonstrate that lamin A serves as a mutually 
exclusive dock for ERK1/2 and the retinoblastoma 
(Rb) protein. Our results reveal that, immediately after their 
postactivation entrance in the nucleus, ERK1/2 dislodge 
Rb from its interaction with lamin A, thereby facilitating 
its rapid phosphorylation and consequently promoting 
E2F activation and cell cycle entry. Interestingly, these 
effects are independent of ERK1/2 kinase activity. We 
also show that cellular transformation and tumor cell pro-
liferation are dependent on the balance between lamin A 
and nuclear ERK1/2 levels, which determines Rb acces-
sibility for phosphorylation/inactivation.
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nucleoplasm, where it is rapidly phosphorylated, leading to E2F-
dependent transcription and cell cycle entry. We also demonstrate 
that the proliferation of tumor cell lines harboring high levels of 
nuclear ERKs and, subsequently, high levels of phosphorylated 
Rb can be attenuated by the overexpression of lamin A, which 
reduces the levels of phosphorylated Rb. Our results disclose a 
critical role for lamin A in cell cycle control through its inter-
action with signaling intermediaries, such as ERKs, and cell cycle 
regulators, such as Rb.
Results
ERK1/2 disrupt Rb binding to lamin A
In a former study, we described that, upon entry in the nucleus 
after activation, a significant amount of ERKs associated to the 
nuclear envelope by directly binding to lamin A. We also identi-
fied the region within lamin A responsible for binding to ERKs, 
which corresponded to a segment spanning amino acids 247–355 
(González et al., 2008). Most interestingly, the same fragment 
had been previously characterized as the region through which 
lamin A bound to the pocked protein Rb (Ozaki et al., 1994). 
Thus, the possibility existed that ERKs and Rb competed for 
association with lamin A. To test this hypothesis, we initially 
looked at how mitogenic stimulation affected endogenous ERKs 
and Rb segregation between the extraction-resistant nuclear 
fraction (ERNF), containing insoluble lamin A and largely as-
sociated to the nucleoskeleton and the nuclear envelope, and the 
soluble nuclear fraction (SNF), mainly representing nucleoplas-
mic lamin A. In NIH3T3 cells, almost all Rb was found associ-
ated to the ERNF under quiescence, but it underwent an abrupt 
redistribution after PDGF stimulation, relocalizing to the SNF 
concomitantly with the incorporation of ERK2 to the ERNF. 
Noticeably, Rb displacement in response to PDGF was fully 
dependent on ERK activation because pretreatment with the 
MAPK ERK kinase (MEK) inhibitor UO126 completely abol-
ished its reallocation (Fig. 1 A). The proportion of Rb that shut-
tled between the ERNFs and SNFs was approximately a third of 
the total cellular levels (Fig. S1, A and B).
Next, we analyzed whether the fluctuations of Rb and 
ERK2 at the ERNF corresponded with their association to 
lamin A. Significant amounts of Rb coimmunoprecipitated with 
lamin A in quiescent NIH3T3, but its levels were progressively 
reduced after PDGF stimulation, in parallel to the formation 
of ERK2–lamin A complexes. The release from lamin A was 
specific for Rb because the levels of LAP2 bound to lamin A 
(Markiewicz et al., 2002) were unchanged in response to PDGF 
(Fig. 1 B and Fig. S1, C–F). Strikingly, concomitant with Rb 
release from its interaction with lamin A, phosphorylated Rb 
appeared in the total lysates at stages in which neither D-, E-, 
nor A-type cyclins were detectable (Fig. 1 C). These results demon-
strated that mitogenic stimulation causes ERK-dependent removal 
of Rb from its complex with lamin A at the ERNF.
To study in further depth the mechanism whereby ERKs 
disrupted Rb–lamin A interaction, we generated constructs aimed 
at bolstering ERK’s constitutive accumulation in the nucleus. 
To this end, we added an SV40 NLS to the C terminus of wild-type 
(wt) ERK2 and several of its mutant forms, which enabled 
of cyclin D1–CDK4 complexes (Cheng et al., 1998). ERKs 
also regulate the levels of the inhibitor p21 by diverse mecha-
nisms (for review see Chambard et al., 2007). Interestingly, 
the necessity for ERKs during G0 exit and G1/S transition is 
abolished in the absence of Rb: Rb-null mouse embryo fibro-
blasts (MEFs) can leave quiescence, progress through the cell 
cycle, and proliferate even when ERK signaling is inhibited 
(D’Abaco et al., 2002).
In addition to the classical control of Rb through phos-
phorylation, some nuclear structural proteins have been shown 
to impact Rb functions in diverse ways. A-type lamins are major 
constituents of the mammalian nuclear lamina, nucleoskeleton, 
and nucleoplasm. They have been shown to regulate key events 
in health and disease through interplay with signaling mol-
ecules, transcription factors, and chromatin-associated proteins. 
Interest in A-type lamins has progressively increased since the 
discovery that LMNA mutations cause severe human diseases, 
which are termed laminopathies (for reviews see Vlcek and 
Foisner, 2007; Andrés and González, 2009). Lamin A–deficient 
cells show an aberrant cell cycle (Boban et al., 2010), but the 
underlying causes are not fully understood. Lamin A binds to 
Rb (Mancini et al., 1994; Ozaki et al., 1994), an association 
that orchestrates Rb subnuclear organization, prevents its pro-
teasomal degradation (Johnson et al., 2004), and facilitates cell 
cycle arrest by the inhibitor INK4A (Nitta et al., 2006). Rb 
also complexes with the lamin A/C–binding protein LAP2 
(Markiewicz et al., 2002). Rb/E2F-dependent gene expression 
and cell cycle progression are regulated by LAP2 expression 
levels (Dorner et al., 2006; Naetar et al., 2008), which may be 
related to the role of LAP2 in maintaining Rb in an adequate sub-
nuclear compartment (Pekovic et al., 2007), apparently an im-
portant requisite for Rb functionality.
Upon stimulation, ERKs translocate to the nucleus within 
minutes (Lenormand et al., 1993). Intriguingly, according to the 
data currently available, it takes hours before their effects on 
cell cycle become evident through transcriptional events such as 
the induction of c-Fos and cyclin D expression. The question re-
mains whether ERKs can also regulate cell cycle entry by other, 
yet undisclosed, mechanisms occurring immediately after their 
entrance in the nucleus. In line with this notion, we have previ-
ously demonstrated that A-type lamins regulate AP-1 transcrip-
tional activity by sequestering preexisting c-Fos at the nuclear 
envelope (Ivorra et al., 2006) in a reversible manner modulated 
by ERKs (González et al., 2008). We found that ERKs also inter-
act with A-type lamins and colocalize with lamin A and c-Fos at 
the nuclear envelope. Serum stimulation brings about the rapid re-
lease of c-Fos from its complex with lamin A in response to ERK- 
dependent phosphorylation, thereby leading to fast c-Fos activa-
tion in advance of de novo c-Fos synthesis (González et al., 2008). 
These findings demonstrate that processes relevant for cell cycle 
progression can be triggered soon after ERK nuclear entry before 
any transcriptional event.
Herein, we describe a novel mechanism whereby ERKs 
directly stimulate cell cycle entry immediately after they pene-
trate in the nucleus. We present data showing that, in a fashion 
independent of their kinase activity, ERKs displace Rb from its 
association to lamin A, thereby promoting its release to the soluble 
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to know whether ERK1 was also able to disrupt Rb–lamin A 
interaction. To this end, we generated an ERK1-NLS construct, 
which was capable of displacing Rb from its complex with 
lamin A as effectively as ERK2 (Fig. 2 D).
It was important to find out whether the rupture of Rb– 
lamin A interaction occurred as a consequence of direct competi-
tion between Rb and ERKs for binding to a common site. For this 
purpose, we took an in vitro approach: GST–lamin 247–355, the 
fragment previously determined to bind both Rb and ERK2 (Ozaki 
et al., 1994; González et al., 2008), was loaded with Rb and incu-
bated with purified, bacterially produced ERK2. It was found that 
increasing concentrations of ERK2 gradually displaced Rb from 
its complex with lamin A (Fig. 2 E). These results demonstrated 
that Rb and ERKs bound to lamin A in a mutually exclusive fash-
ion and that ERKs can directly displace Rb from lamin A.
It has been demonstrated that Rb also associates with LAP2, 
a protein that binds to nucleoplasmic lamin A (Markiewicz et al., 
2002). Thus, it was of interest to find whether ERKs were also 
capable of interfering with Rb binding to LAP2. As expected, 
endogenous Rb and LAP2 coimmunoprecipitated in NIH3T3 
a strict nuclear localization for all of these recombinant pro-
teins (Fig. 2 A). We then examined the capability of ERK2 
to break lamin A–Rb complexes in quiescent NIH3T3 cells. 
Interestingly, Rb was displaced from its association to lamin 
A by ERK2-NLS wt just as efficiently as by a kinase-deficient 
mutant (DK) K52R (Ajenjo et al., 2000) and by an unphos-
phorylatable form (AEF; Wolf et al., 2001). Contrarily, a dele-
tion mutant lacking the insert region (INS), which we had 
previously identified as responsible for ERK2 binding to lamin 
A (González et al., 2008), was impaired for dislodging Rb from 
lamin A. These results were ascertained further by fluorescence 
resonance energy transfer (FRET) experiments, which allow 
the measurement of protein–protein interactions at a molecular 
resolution of 1–10 nm (Kenworthy, 2001). U2OS cells were 
transfected with CFP–lamin A and either YFP-Rb or YFP as 
a negative control. FRET efficiency was prominent in cells 
expressing YFP-Rb, but it was markedly reduced in cells co-
transfected with ERK2-NLS wt or DK, though not in those co-
transfected with the INS mutant (Fig. 2 C), in full consonance 
with the results obtained by biochemical means. We wanted 
Figure 1. Mitogenic stimulation releases Rb 
from lamin A complexes in an ERK-dependent 
fashion. (A) Agonist stimulation provokes Rb re-
lease from the nuclear envelope. NIH3T3 cells 
were serum starved for 18 h and subsequently 
stimulated with 20 ng/ml PDGF for the indi-
cated periods. Where shown (UO), cells were 
pretreated for 30 min with 10 µM UO126 
before 30-min stimulation with PDGF. ERNFs 
and SNFs were obtained, and equal amounts 
of fractions were fractionated by SDS-PAGE. 
Total lysates (TL) from parallel plates are also 
shown. The indicated proteins were identified 
by immunoblotting ( protein of interest). Num-
bers show Rb levels quantified relative to the 
highest signal. (B) Mitogenic stimulation breaks 
lamin A–Rb interaction. Cells were stimulated 
as in A. At the shown time points, cellular 
lysates were immunoprecipitated for lamin A. 
Immunoprecipitates (IP) and the correspond-
ing total lysates were probed for the indicated 
proteins by immunoblotting. Immunoblots are 
representative of three independent experi-
ments. (C) Mitogenic stimulation induces rapid 
Rb phosphorylation. Total lysates from cells 
treated as in A and B were probed for the in-
dicated proteins by immunoblotting. A total ly-
sate from exponentially growing cells (G) was 
used as a control. Molecular masses (given in 
kilodaltons) are shown in parentheses after the 
protein name.
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was unchanged in the presence of the nuclear ERK2 forms 
(Fig. 3 B). Overall, these results demonstrated that ERKs can 
directly displace Rb from its interaction with the fraction of lamin 
A present in the ERNF without affecting Rb or lamin A binding 
to other proteins such as LAP2. Importantly, they also disclose 
that ERK phosphorylation and kinase activity are not required 
for such a purpose.
cells, but the expression of ERK2-NLS, wt, and DK did not 
affect such interaction whatsoever (Fig. 3 A). Moreover, neither 
of these ERK2 forms could be detected in anti-LAP2 immuno-
precipitates, indicating that ERKs do not bind to LAP2. By the 
same approach, we also investigated whether ERKs could impact 
the interaction between lamin A and LAP2. Our results showed 
that the amount of LAP2 coimmunoprecipitating with lamin A 
Figure 2. Nuclear ERKs dislodge Rb from lamin A complexes. (A, left) Nuclear localization of the different HA-tagged ERK2-NLS forms as determined in 
nuclear (nuc) and cytoplasmic (cyt) fractions of 293T cells transfected with 1 µg of the indicated constructs: control cells transfected with vector DNA (), 
ERK2 wt (wt), ERK2 DK (DK), ERK2 unphosphorylatable mutant (AEF), and ERK2 insert region deletion mutant (INS). (right) The purity of the fractions 
was ascertained using lamin A and Rho GDI as nuclear and cytoplasmic markers, respectively. (B) Nuclear ERK2 disrupts lamin A–Rb interaction. NIH3T3 
cells were transfected with 1 µg each of the indicated ERK2-NLS constructs, grown until confluence, and kept in 0.5% CS for 18 h. Cellular lysates were 
immunoprecipitated for lamin A, and immunoprecipitates (IP) and the corresponding total lysates (TL) were probed by immunoblotting for the indicated 
proteins ( protein of interest). (C) Effects of nuclear ERK2 on lamin A–Rb interaction analyzed by FRET in U2OS cells using the acceptor-photobleaching 
method. Cells were transiently cotransfected with 5 µg ECFP–lamin A plus 5 µg each of the different plasmids as indicated. Data show quantification 
of protein–protein interactions calculated as the percentage of CFP fluorescence increments after YFP photobleaching in 30–50 cells. *, P < 0.05 and 
**, P < 0.01. Results show means ± SEM. (D) ERK1 disrupts lamin A–Rb interaction as effectively as ERK2. NIH3T3 cells were transfected with 1 µg each of 
HA-tagged ERK1-NLS and ERK2-NLS and processed as in B. Cellular lysates were immunoprecipitated with an antibody against lamin A or with preimmune 
serum (PI). Immunoprecipitates and the corresponding total lysates were probed by immunoblotting for the indicated proteins. (E) ERK2 displaces Rb from 
lamin A in vitro. GST and GST–lamin 247–355 were loaded with YFP-Rb from transfected U2OS cell extracts, incubated with the indicated amounts of 
purified His-tagged ERK2 for 1 h, and tested for their interaction by Western blotting. Molecular masses (given in kilodaltons) are shown in parentheses 
after the protein name.
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To this end, we cotransfected wt MEFs and counterparts deficient 
for Rb (Zalvide and DeCaprio, 1995) with an E2F-responsive 
luciferase reporter plus the ERK2-NLS constructs previously 
mentioned. With the exception of the INS mutant, all the 
ERK2-NLS forms induced a potent E2F-dependent transcrip-
tional activity in wt MEFs (Fig. 4 C). Contrarily, in Rb-null 
MEFs that, expectedly, displayed much higher basal E2F activ-
ity, E2F was insensitive to the overexpression of the nuclear 
ERK constructs. These results demonstrate that E2F response 
to nuclear ERKs is completely dependent on Rb inactivation 
and that the sole presence of ERKs at the nucleus, even when 
deprived of kinase activity, is sufficient to induce Rb inactiva-
tion by phosphorylation and E2F transcriptional activity.
Nuclear ERKs induce cell cycle entry in an 
Rb- and lamin A–dependent fashion
Having determined that the presence of ERKs at the nucleus 
was sufficient to induce a fast disruption of lamin A–Rb com-
plexes, Rb phosphorylation, and E2F-mediated transcription, 
we proceeded to examine whether these events were accompa-
nied by an augmented cell cycle entry. As such, we monitored 
cell cycle progression in MEFs transiently transfected with 
ERK1-NLS and the different ERK2-NLS forms, which were 
synchronized by an overnight aphidicolin block. Remarkably, 
even immediately after the release from the aphidicolin block, 
the cells expressing ERK1 and ERK2, wt, DK, and AEF exhib-
ited an enhanced cell cycle entrance, with 15% of the cells 
in G2/S phases versus 6% detected in control cells (Fig. 5 A, 
top) and in cells expressing the INS mutant (not depicted). 
Such an effect was exacerbated after 16 h in culture with 0.5% 
serum, a stimulus insufficient to induce cell cycle progression 
in control cells but enough to drive into G2/S phases 30% of 
the cells transfected with either wt, DK, or AEF ERK2. Similar re-
sults were obtained in NIH3T3 cells (Fig. S2). In agreement, the 
proliferation rate of NIH3T3 cells stably expressing wt ERK2-
NLS was significantly enhanced in comparison to parental cells 
(Fig. 5 B). Importantly, cell cycle progression induced by ERKs 
was dependent on lamin A because its overexpression was suf-
ficient to suppress the growth advantage conferred by ectopic 
nuclear ERK2 (Fig. 5 A, top and bottom). Furthermore, nuclear 
ERK’s capacity to promote cell cycle transit was dependent on 
Rb, as it did not significantly alter the percentage of cycling 
Rb-null MEFs, both immediately after the release from the aphidi-
colin block and 16 h after stimulation. Moreover, the check posed 
by lamin A overexpression on nuclear ERK2-induced cell cycle 
entry in normal MEFs was completely lost in Rb-null MEFs 
(Fig. 5 A), indicating that the limiting effect exerted by lamin A 
on cell cycle progression was mediated by its interplay with Rb. 
Accordingly, the cell cycle profile in LMNA-null MEFs (Sullivan 
et al., 1999) was indistinguishable between control cells and those 
transfected with the ERK2-NLS constructs, further endorsing the 
notion that the ability of nuclear ERKs to promote advancement 
through the cell cycle is regulated by lamin A.
Next, we examined whether nuclear ERKs, capable of induc-
ing Rb phosphorylation and cell cycle entry under our experimen-
tal conditions, were affecting other cell cycle regulators previously 
described to be under the influence of their signals at later stages of 
Rb release from lamin A complexes 
promotes its inactivation
It was essential to understand the functional consequences of 
the disruption of Rb–lamin A interaction in response to the 
presence of ERKs in the nucleus. A hallmark of Rb function 
is its inactivation by phosphorylation leading to the release of 
E2F transcription factors (Weinberg, 1995). Thus, we performed 
immunoblotting using antibodies specific for phosphorylated 
Rb to analyze its activation status in lysates from quiescent 
NIH3T3 cells transfected with the different ERK2-NLS con-
structs. We found that the levels of phosphorylated Rb were 
markedly incremented in cells expressing such constructs, with 
the exception of those harboring INS, at a time in which the 
expression of A, D, and E cyclins was undetected (Fig. 4 A). 
We sought to determine whether the rise in Rb phosphorylation 
was related to its release from the nuclear lamina. As such, we 
isolated ERNFs and SNFs and found that phosphorylated Rb was 
found exclusively in the SNF from cells transfected with ERK2-
NLS wt, AEF, and DK, in which Rb had been displaced from the 
ERNF. Noticeably, Rb phosphorylation was most prominent at 
residues S807 and S811. Contrarily, in cells expressing INS, 
in which Rb remained at the ERNF, phosphorylated Rb was un-
detectable in the soluble fraction. In all instances, the levels of 
phosphorylated Rb in the ERNF were minimal (Fig. 4 B).
In light of these results, we tested whether ERK-induced re-
lease of Rb from insoluble lamin A and its subsequent phosphory-
lation also resulted in an increment on E2F transcriptional activity. 
Figure 3. ERK2 does not affect other lamin A and Rb interactions.  
(A) ERK2 does not affect LAP2–Rb interaction. NIH3T3 cells were trans-
fected with 1 µg each of vector (), HA-ERK2-NLS-wt (wt), and HA-ERK2-DK 
(DK), grown until confluence, and kept in 0.5% CS for 18 h. Cellular 
lysates were immunoprecipitated with an antibody against LAP2 or with 
preimmune serum (PI), and immunoprecipitates (IP) and total lysates (TL) 
were probed for the indicated proteins ( protein of interest). (B) ERK2 
does not affect LAP2–lamin A interaction. The experiment was per-
formed as in A, but cellular lysates were immunoprecipitated for lamin A. 
Molecular masses (given in kilodaltons) are shown in parentheses after the 
protein name.
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and tumor cell proliferation. To this aim, we conducted focus 
formation assays in NIH3T3 fibroblasts, as induced by the 
oncogene v-Src with or without ERK2-NLS wt. We found 
that the presence of nuclear ERK2 markedly enhanced v-Src 
transforming potential, an effect that could be reverted by the 
cotransfection of lamin A (Fig. 6 A). This observation was 
substantiated further under more physiological conditions. 
The MCF7 cell line is derived from a breast ductal carcinoma 
and displays highly tumorogenic and metastatic characteris-
tics (Soule et al., 1973). MCF10A cells are also derived from 
mammary epithelium but are nontumorogenic and retain many 
features reminiscent of normal cells (Soule et al., 1990). 
Interestingly, we found that MCF7 cells expressed much more 
ERKs, particularly ERK1, than MCF10A (Fig. 6 B), most 
of which was present at the nucleus (Fig. 6 C). Moreover, in 
the cell cycle (for review see Chambard et al., 2007). It was found 
that the levels of cyclin D3 and of the inhibitors p21 and p27 were 
unchanged by the expression of ERK2-NLS DK both in wt and 
in LMNA/ MEFs (Fig. 5 C). Conversely, in wt MEFs, phosphory-
lated Rb was markedly higher in those expressing ERK2-NLS DK 
compared with vector-transfected controls, a difference that could 
not be detected in LMNA/ MEFs. These results demonstrated 
that under our experimental settings, the induction of cell cycle 
progression by nuclear ERKs is caused by their capacity to facili-
tate Rb phosphorylation in a fashion dependent on lamin A.
Lamin A restrains transformation  
and proliferation of tumor cells
Finally, we evaluated how the balance among ERKs, lamin A, 
and Rb impacted biological processes such as transformation 
Figure 4. ERK-induced Rb release from lamin 
A complexes facilitates Rb phosphorylation. 
(A) Nuclear ERK2 promotes Rb phosphoryla-
tion. NIH3T3 cells were transfected with 1 µg 
each of vector () or the indicated ERK2-NLS 
constructs, grown until confluence, and kept in 
0.5% CS for 18 h. The indicated proteins ( pro-
tein of interest) were identified in total lysates 
by immunoblotting. (B) Phosphorylated Rb ap-
pears at the SNF in response to nuclear ERKs. 
Cells were treated as in A. ERNFs and SNFs 
were separated, and the indicated proteins 
were identified by immunoblotting. Numbers 
show Rb and phosphorylated Rb levels quanti-
fied relative to the levels detected in a total cell 
extract (TL) run alongside. (C) Nuclear ERK2 
promotes E2F transactivation. E2F transacti-
vation was examined in wt and Rb-null MEFs 
transfected with 1 µg 3×-wt-E2F-luc plus 1 µg 
of the indicated ERK2-NLS constructs. Results 
show means ± SEM of three independent ex-
periments relative to vector-transfected cells (). 
**, P < 0.005 and ***, P < 0.001 relative to 
levels in control cells. Molecular masses (given 
in kilodaltons) are shown in parentheses after 
the protein name.
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Figure 5. Rb- and lamin A–dependent cell cycle progression induced by nuclear ERKs. (A, top) Nuclear ERK2 enhances cell cycle progression. MEFs (wt, 
Rb/, and LMNA/) were transfected as shown with 1 µg ERK1-NLS and ERK2-NLS forms (wt, dead kinase [DK], unphosphorylatable mutant [AEF], and 
HA–lamin A [lam. A]) as indicated. Cells were synchronized by aphidicolin block, and cell cycle phases were analyzed by flow cytometry immediately 
after the block release and after 16 h of stimulation with 0.5% FCS. Graphs show a representative experiment out of three independent events. (bottom) 
Expression levels of cotransfected lamin A and ERK2-NLS wt. (B) Nuclear ERK2 enhances proliferation rate. Proliferation kinetics of NIH3T3 cell lines: 
parental (control) and stably expressing ERK2-NLS wt (wt). Results show means ± SEM of three independent experiments. (C) Nuclear ERK2 does not affect 
other cell cycle regulators. MEFs, wt, and LMNA/ (/) and parental () or stably expressing ERK2-NLS DK (DK) were analyzed for the expression of 
the indicated cell cycle regulators by immunoblotting. For p21 and p27, total cell lysates from starved cells are shown. For the rest, lysates correspond to 
cells grown in 5% FCS. Molecular masses (given in kilodaltons) are shown in parentheses after the protein name.
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Figure 6. Biological effects of ERK/Rb–lamin A balance. (A) Nuclear ERK2 promotes and lamin A hampers transformation. Focus formation assays in 
NIH3T3 cells transfected with 0.25 µg v-Src plus 1 µg each ERK2-NLS wt with or without lamin A. ***, P < 0.005 and *, P < 0.05. (B) Relative levels of 
ERKs, phospho-Rb, and lamin A in MCF7 and MCF10A cells. Total lysates were analyzed for the expression of the indicated proteins ( protein of interest) 
by immunoblotting. (C) MCF7 cells exhibit high levels of nuclear ERKs. Nuclear (N) and cytoplasmic (C) extracts from MCF7 and MCF10A cells were 
analyzed for their content on ERKs by immunoblotting. The purity of the fractions was ascertained using lamin A and Rho GDI as nuclear and cytoplasmic 
markers, respectively. (B and C) Numbers show ERK1 and ERK2 expression levels quantified relative to the highest signal. (D) Lamin A attenuates the 
proliferation rate of tumor cells. Proliferation kinetics of the cell lines MCF10A, MCF7, and MCF7 overexpressing lamin A. (E) Lamin A down-regulates 
phospho-Rb levels in tumor cells. (top) Total lysates (TL) from MCF7 cells, parental and overexpressing lamin A, were analyzed for the expression of the 
indicated proteins by immunoblotting. (bottom) Enhanced Rb–lamin A association in MCF7 cells overexpressing lamin A, as determined in anti–lamin A 
immunoprecipitates (IP). Molecular masses (given in kilodaltons) are shown in parentheses after the protein name. Results show means ± SEM of three 
independent experiments.
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kinase activity, as mutant forms devoid of catalytic function can 
trigger Rb phosphorylation under serum deprivation conditions 
by virtue of their ability to disrupt the Rb–lamin A complexes. 
However, we cannot discard that the unknown Rb kinase is 
regulated by ERKs in a kinase-independent fashion. Indeed, ERK2 
substrates such as PARP-1 (Cohen-Armon et al., 2007), topo-
isomerase II (Shapiro et al., 1999), and MKP3 (Camps et al., 1998) 
are activated by direct interaction with ERK2 without involving 
its kinase activity.
We have demonstrated that ERK nuclear influx causes the 
immediate dislodgement of Rb from its association to lamin A, 
thereby triggering cell cycle entry. This result unveils a previ-
ously undocumented role for ERKs in the regulation of the ini-
tial steps of the cell cycle and complements previous studies 
that addressed ERK’s importance at later stages, such as mid-G1 
and G1/S transition, but had not examined events previous to 
1 h after stimulation (Jones and Kazlauskas, 2001; Yamamoto 
et al., 2006; Villanueva et al., 2007), as we have herein. It is note-
worthy that, in agreement with our findings, the importance of 
ERKs for the onset of cell cycle had been noticed before (Jones 
and Kazlauskas, 2001). Furthermore, we show that cells defi-
cient for Rb are refractory to the increments on E2F-mediated 
transcription and on cell cycle progression induced by nuclear 
ERKs, in full consonance with previous experiments (D’Abaco 
et al., 2002). One interpretation could be that ERK’s mission to 
disrupt Rb–lamin A interaction would be unnecessary in the ab-
sence of Rb. In support of this notion, we show that (a) lamin A’s 
inhibitory effect on ERK-induced cell cycle transit is lost in 
Rb/ cells and (b) cells devoid of lamin A are insensitive to 
the stimulatory effects of ERKs on cell cycle entry. These data 
clearly suggest that lamin A’s regulatory effect on cell cycle is 
based, to a significant extent, on its role as a mutually exclusive 
dock for ERKs and Rb.
The nuclear lamina and the nucleoskeleton are thought to 
play important roles in gene regulation (Schneider and Grosschedl, 
2007). It has been demonstrated that gene-rich chromatin re-
gions associate with nuclear structures rich in lamin A (Shimi 
et al., 2008) and that lamin A can act as a transcriptional re-
pressor at different promoters (Lee et al., 2009; Ottaviani et al., 
2009). In addition, it is well known that Rb is bound to E2F- 
regulated promoters in resting cells (Weintraub et al., 1995). 
Based on these previous notions and on our present results, we 
propose the model depicted in Fig. 7: under quiescence, Rb 
would be bound to insoluble lamin A, which is present at the 
nuclear lamina and other structures of the nucleoskeleton. At the 
same time, Rb would also be bound to E2F-regulated promoters 
via E2F. In response to mitogenic stimulation, ERKs will enter 
the nucleus and immediately displace Rb from its complex with 
insoluble lamin A, releasing it to the soluble nucleoplasm, where 
it will be available for phosphorylation by some yet unidentified 
Rb kinase, thereby triggering Rb inactivation, E2F release, and 
transcriptional activation of the target promoters.
It is worth noticing that the disruption of lamin A–Rb inter-
action by ERKs seems to be quite specific, as we found that the 
association between LAP2 and Rb is unaffected. Moreover, 
lamin A interaction with LAP2 is also insensible to nuclear 
ERKs. Intriguingly, if ERKs bind to lamin A and lamin A binds 
agreement with the aforementioned findings, MCF7 cells ex-
hibited much higher levels of phosphorylated Rb than MCF10A 
cells (Fig. 6 B). Consequently, the proliferation rate of MCF7 
cells was 70% higher than that for MCF10A (Fig. 6 D). 
We then generated a line of MCF7 cells stably overexpressing 
lamin A. These cells exhibited much lower levels of phosphory-
lated Rb compared with parental MCF7 cells (Fig. 6 E, top) 
and, consequently, an augmented association of Rb to lamin A 
(Fig. 6 E, bottom). These alterations, resulting from lamin A 
overexpression, coincided with a reduction in the proliferation 
rate of MCF7–lamin A cells to levels similar to those found in 
MCF10A cells (Fig. 6 D). Overall, these results suggest that 
biological outputs such as transformation and proliferation are 
highly dependent on the balance between lamin A and the levels 
of nuclear ERKs, which determine the amount of Rb accessible 
for phosphorylation and, subsequently, regulate cell cycle entry 
and cellular proliferation.
Discussion
A previous study from our laboratories demonstrated that, upon 
nuclear entry in response to stimulation, ERKs bind to lamin A/C 
and, in so doing, trigger immediate pretranscriptional events 
such as rapid c-Fos activation (González et al., 2008). Follow-
ing this line of research, herein, we report that ERK interaction 
with lamin A also orchestrates a novel mechanism for cell cycle 
regulation by facilitating a fast phosphorylation of Rb, preced-
ing other transcriptional events whereby ERKs are known to 
control the cell cycle machinery (for review see Chambard et al., 
2007). We noticed that ERKs and Rb bind to lamin A through 
the same region (Ozaki et al., 1994; González et al., 2008). 
We now demonstrate that they do so in a competitive fashion 
with remarkable functional consequences. In an unprecedented 
fashion, ERKs physically dislodge Rb from its interaction with 
insoluble lamin A, releasing Rb to the SNF, thereby making 
possible its inactivation by phosphorylation, the subsequent 
activation of E2F transcription factors, and, ultimately, cell 
cycle progression. These data suggest that lamin A interaction 
with Rb prevents its inactivation, either by inhibiting its phos-
phorylation or by favoring its dephosphorylation. Accordingly, 
the rupture of Rb–lamin A complexes, either by competitive bind-
ing, as we show here for ERKs, or by the absence of lamin A 
as previously demonstrated (Van Berlo et al., 2005), increases the 
levels of phosphorylated Rb.
Our data indicate that Rb phosphorylation occurs rapidly 
after ERK nuclear influx, long before the assembly of cyclin D–
CDK4/6 or cyclin E-A–CDK2 complexes, the main inactiva-
tors of Rb (Weinberg, 1995). This indicates that some other kinase 
must be phosphorylating Rb at very early stages of the cell cycle. 
This notion could be inferred from a previous study showing 
that, in MEFs lacking all interphase Cdks (CDK2, CDK3, 
CDK4, and CDK6), Rb is phosphorylated, and progression 
through the cell cycle is achieved (Santamaría et al., 2007). 
Evidently, a major goal will be to identify the responsible 
kinase, the transcriptional Cdks (Malumbres and Barbacid, 2009) 
being attractive candidates. Irrespective of its identity, our 
results unveil that such an Rb kinase is not regulated by ERK 
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which can also forestall cellular transformation as induced by 
the potent oncogene v-Src. It has been shown that cell lines 
deficient for lamin A/C proliferate faster (Johnson et al., 2004; 
Van Berlo et al., 2005; Ivorra et al., 2006; Nitta et al., 2006). It is 
also known that lamin A levels inversely correlate with prolifera-
tion rates in different tissues (Broers et al., 1997) and that expres-
sion of A-type lamins is a marker of tumor cell differentiation 
(Foster et al., 2010). Our present results disclose a molecular 
mechanism whereby lamin A could be exerting the aforemen-
tioned antitumoral effects through the regulation of cell cycle entry 
by virtue of its capacity to prevent Rb inactivation immediately 
unleashed by ERK entry into the nucleus after mitogenic 
stimulation. A major goal will be to determine whether defects 
on such a mechanism underlie the pathogenesis of some severe 
medical conditions that result from mutations in A-type lamins.
Materials and methods
Plasmids
ERK2 DK, AEF, INS, and ECFP–lamin A have been previously described 
(Ajenjo et al., 2000; Wolf et al., 2001; Ivorra et al., 2006; Casar 
et al., 2007). To generate nuclear-targeted HA-ERK2-NLS forms, the SV40 
T antigen nuclear localization signal (PKKKRKV) was introduced by PCR 
directly downstream of ERK2’s last codon. An identical strategy was used to 
generate HA-ERK1-NLS. pEYFP-Rb was generated by subcloning the full-length 
to LAP2, ERKs should be detected in LAP2 immunoprecipi-
tates, but we have found that this is not the case. This could have a 
technical explanation: the macrocomplex is not stable enough to 
resist the immunoprecipitation conditions. However, we hypoth-
esize a second possibility. We have shown that ERKs bind to in-
soluble lamin A, whereas LAP2 associates with nucleoplasmic 
lamin A (Dorner et al., 2006; Naetar et al., 2008). As such, ERKs 
and LAP2 would not be bound to the same pool of lamin A. 
This opens the possibility that two distinct populations of lamin A 
may be orchestrating cell cycle progression through the inter-
action with Rb and two different regulators, ERKs versus LAP2, 
at two different stages, immediate G0 exit, as we show here, versus 
G1 (Dorner et al., 2006; Naetar et al., 2008). It is also possible that 
these events may take place at different sublocalizations within 
the nucleus, for example, the nuclear periphery/lamina versus 
internal nuclear zones. These notions will require further studies.
Finally, we have investigated how ERK/lamin A–Rb inter-
play impacts biological processes relevant to carcinogenesis, 
such as cellular transformation and tumor cell proliferation. 
We demonstrate that in physiological settings, a direct correla-
tion exists among ERK nuclear levels, Rb phosphorylation, and 
cellular proliferation. Noticeably, Rb phosphorylation and pro-
liferation can be attenuated by the expression of ectopic lamin A, 
Figure 7. A model for ERK/lamin A–medi-
ated regulation of Rb function. In quiescent 
cells, ERKs reside at the cytoplasm. At the 
nucleus, Rb is bound to lamin A, which main-
tains it in an active state bound to E2F and 
E2F-regulated promoters. After mitogenic stimu-
lation, phosphorylated ERKs enter the nucleus 
and disrupt Rb–lamin A interaction. Rb is re-
leased to the nucleoplasm, where it will be 
phosphorylated/inactivated by an unidentified 
Rb kinase, liberating E2F and setting in motion 
the cell cycle machinery.
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Subnuclear fractionation
ERNFs and SNFs were separated as briefly described: cells were washed, 
scraped into TEN buffer (150 mM NaCl, 1 mM EDTA, and 40 mM Tris, 
pH 7.4), collected by centrifugation, and resuspended in lysis buffer 
(10 mM Hepes, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 
1 mM DTT, and 0.5 mM PMSF). After 15 min on ice, NP-40 was added 
to a final concentration of 0.5%. Lysates were centrifuged, and the nuclear 
pellet was collected, resuspended in 20 mM of ice-cold Hepes, pH 7.9, 
0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, and 1 mM PMSF, soni-
cated for 1 min, and vigorously vortexed at 4°C for 15 min. The nuclear 
lysate was centrifuged at 15,000 g for 45 min at 4°C to obtain the super-
natant (SNF) and the pellet (ERNF) that were resuspended in lysis buffer 
plus NP-40 (1% to a volume equal to that of the SNF). In the experiments 
in which total lysates are run alongside SNFs and ERNFs, these were col-
lected from parallel plates using the lamin A immunoprecipitation protocol 
described in Lamin A coimmunoprecipitation assays.
FRET
U2OS cells were cotransfected with calcium phosphate (Sigma-Aldrich) 
using 5 µg ECFP–lamin A plus 5 µg each of the different combinations of 
plasmids as indicated in Fig. 2 C. Images were acquired on a confocal 
microscope (TCS/SP5; Leica) with a 63× NA 1.4 oil immersion objective 
at room temperature using glycerol as an imaging medium. An argon laser 
line of 458 nm was used to excite CFP (photomultiplier tube window of 
465–505 nm), and a 514-nm line (10% laser intensity for acquisition and 
100% for every five frames for photobleaching) was used to excite YFP (photo-
multiplier tube window of 525–600 nm). FRET experiments were performed 
in 4% paraformaldehyde-fixed cells using the acceptor-photobleaching 
method (Kenworthy, 2001) in which FRET efficiency is calculated as the 
relative increase in total intensity as a result of the reduction or elimination 
of energy transfer when the acceptor is photobleached. Specifically, the per-
centage of donor total intensity (area multiplied by mean intensity) that in-
creases its fluorescence after acceptor photobleaching was quantified in the 
nucleus using the following equation: FRET = (Cafter – Cbefore)/Cafter × 100, 
in which Cbefore and Cafter are the total fluorescence intensity of the CFP chan-
nel before and after photobleaching, respectively. Image quantification was 
performed using MetaMorph software (MDS Analytical Technologies).
Luciferase assays
Luciferase assays were performed in MEFs basically as described previ-
ously (Sanz-Moreno et al., 2003) using a 3×-wt-E2F-luc reporter plasmid 
that contains three wt E2F binding sites upstream of the luciferase gene 
(Krek et al., 1993) provided by A. Zubiaga (University of Bilbao, Bilbao, 
Spain). In brief, cells were transfected using Lipofectamine reagent with a 
-galactosidase reporter and the E2F reporter plasmid. The total amount of 
DNA for each transfection was kept constant at 5 µg using pCDNA3. The 
luciferase activities were determined using a commercial kit (Dual Luciferase 
reporter assay kit; Promega) according to the manufacturer’s instructions 
and normalized by dividing by the -galactosidase activity.
Cellular proliferation assays
Cellular proliferation assays were performed exactly as previously described 
(Matallanas et al., 2006). In brief, cells were plated at low density in 6-well 
plates and cultured for different time intervals under standard conditions. 
Cells were detached and scored by standard cell-counting techniques at the 
indicated intervals.
Cell cycle analyses
To be synchronized, cells were treated for 24 h with 1 µM aphidicolin 
(Sigma-Aldrich) in DMEM. Subsequently, cells were washed twice with PBS 
and stimulated with 0.5% FBS for 16 h. Cells were trypsinized, washed 
three times in PBS, fixed in 70% ethanol for 30 min at 4°C, resuspended 
in 500 µl of staining solution (PBS, 100 µg/ml RNase A, and 75 µg/ml 
propidium iodide), incubated for 2 h at 4°C in a light-proof container, and 
subjected to cytometric analysis. Cells were analyzed with a flow cytome-
ter (FACSCanto II; BD) using the DiVa 6.1.1 software.
Statistical analyses
Statistical analyses were performed using Prism 4.0 software (GraphPad 
Software, Inc.). Results show analysis of variance performed by Bonferroni 
multiple comparisons test.
Online supplemental material
Fig. S1 shows the specificity of the anti–lamin A immunoprecipitations, the 
quantification of the Rb levels that fluctuate between the lamin A soluble and 
insoluble fractions, the down-regulation of Lap2 levels, and the specificity 
human Rb1 into pEYFP-C1 (Takara Bio Inc.). pCEFL HA–lamin A was 
a gift from J.M.P. Freije and C. Lopez-Otín (University of Oviedo, 
Oviedo, Spain).
Cell culture
MEFs and MCF7 cells were grown in Dulbecco’s minimum essential me-
dium (DMEM) and 10% FCS. NIH3T3 was grown in DMEM and 10% CS. 
MCF10A was grown in DMEM F12 supplemented with 5% horse serum, 
20 ng/ml EGF, 0.5 µg/ml hydrocortisone, and 10 µg/ml insulin. Cells 
were transfected with Lipofectamine reagent (Invitrogen). ERK2-NLS 
stable cell lines were generated by pooling 10 clones previously tested 
for stable expression. UO126 was obtained from Promega, and PDGF 
was purchased from Invitrogen. Rb/ MEFs were provided by J. Zalvide 
(University of Santiago, Santiago, Spain). Lamin/ MEFs were provided by 
O. Meucci (Drexel University, Philadelphia, PA).
Antibodies
The mouse monoclonals used were anti-HA, anti-ERK2, phospho-ERK, and 
phospho-Lap2. The rabbit polyclonals used were anti–lamin A, anti-Rb, 
anti-panERK, anti–Rho guanine dissociation inhibitor (GDI), anti–Elk-1, 
anti–cyclin D3, anti-p21, and anti-p27. The goat polyclonal used was anti-
actin. All were obtained from Santa Cruz Biotechnology, Inc. Mouse mono-
clonal anti-ERK1 was obtained from BD. Rabbit polyclonal anti–phospo-Rb 
(S780, S795, and S807/811) was purchased from Cell Signaling Tech-
nology. Mouse monoclonal anti–lamin A/C Manlac was provided by 
G.E. Morris (MRIC Biotechnology Group, Wrexham, England, UK).
Lamin A coimmunoprecipitation assays
Cells were washed in ice-cold PBS and lysed in 20 mM Hepes, pH 7.5, 
10 mM EGTA, 40 mM glycerophosphate, 1.5% NP-40 (Fluka), 2.5 mM 
MgCl2, 2 mM orthovanadate, 1 mM DTT, 1 mM PMSF, and 10 µg/ml 
aprotinin/leupeptin. After 30 min on ice, lysates were cleared by centrifu-
gation, 0.1 vol was separated to be loaded as the total lysate, and the rest 
were incubated with antibody rocking at 4°C for 4 h. Protein G–Sepharose was 
added and agitated at 4°C for 12 h. Beads were collected and washed 
three times with NP-40/PBS. Pellets were resuspended in 5× Laemmli 
buffer, boiled for 5 min, and fractionated by SDS-PAGE.
Immunoblotting
Total lysates and affinity precipitates were fractionated by SDS-PAGE and 
transferred onto nitrocellulose filters. Immunocomplexes were visualized by 
enhanced chemiluminescence detection (GE Healthcare) with horseradish 
peroxidase–conjugated secondary antibodies (Bio-Rad Laboratories).
In vitro pull-down assays
Bacterially produced His-ERK2 was purified according to the manufacturer’s 
instructions (Protino Ni-IDA 150 packed columns; Macherey-Nagel). 
GST and GST–lamin A 247–355 bound to glutathione–Sepharose 4B 
beads were incubated in cell lysates from U2OS cells transfected with 
YFP-RB1. After incubation for 2 h at 4°C, the beads were collected and 
washed twice with cold PBS and 1% NP-40/PBS and twice with lysis buffer. 
Where indicated, different amounts of His-ERK2 were added, and, after in-
cubation for 2 h at 4°C, the beads were collected and washed as before. 
Pellets were resuspended in 2× Laemmli buffer, boiled for 5 min, and sepa-
rated by 10% SDS-PAGE.
Focus-forming assays
Assays were performed basically as previously described (Arozarena 
et al., 2000). In brief, subconfluent NIH3T3 cultured in DMEM and 10% CS 
were transfected with the indicated constructs using Lipofectamine reagent 
according to the manufacturer’s instructions. After 10–15 d in culture, plates 
were stained in 5% GIEMSA, and foci were scored.
Nucleocytoplasmic fractionation
Nucleocytoplasmic fractionation was performed in 20 mM Hepes buf-
fer, pH 7.4, basically as described previously (Casar et al., 2007). 
In brief, cells were collected in 50 mM -glycerophosphate, pH 7.3, 
1 mM EDTA, 1 mM EGTA, and 1 mM DTT, centrifuged, and lysed in 
40 mM Hepes, pH 7.5, 5 mM EGTA, 0.1% NP-40, 5 mM MgCl2, 1 mM 
DTT, 1 mM VO4, and 1 mM benzinamide. The lysate was vortexed vigor-
ously and centrifuged to obtain the cytoplasmic fraction as supernatant. 
Nuclei were resuspended in 50 mM -glycerophosphate, pH 7.3, 
0.2 mM EDTA, 420 mM NaCl, 1.5 mM MgCl2, 1 mM DTT, and 25% 
glycerol, sonicated briefly on ice, vortexed, and centrifuged, and the 
precipitated cell debris was discarded.
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